Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Buy
56
GDOC Quote, Financials, Valuation and Earnings
Last price:
$34.36
Seasonality move
:
-4.33%
Day range:
$34.26 - $34.44
52-week range:
$28.34 - $37.33
Dividend yield:
0.33%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
2.5K
Avg. volume:
2.7K
1-year change:
1.67%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | -- | -- | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | -- | -- | -- | -- |
|
TMED
Trimedyne
|
-- | -- | -- | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
$34.44 | -- | -- | -- | $0.11 | 0.33% | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
$25.64 | -- | -- | -- | $0.11 | 0% | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
$29.45 | -- | -- | -- | $0.09 | 0.87% | -- |
|
MEDI
Harbor Health Care ETF
|
$30.84 | -- | -- | -- | $0.08 | 0.24% | -- |
|
TMED
Trimedyne
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
$156.25 | -- | -- | -- | $0.66 | 1.59% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | 0.352 | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | 0.577 | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | 0.489 | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | 0.396 | -- | -- |
|
TMED
Trimedyne
|
-- | 0.000 | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -0.123 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
GDOC
Goldman Sachs Future Health Care Equity ETF
|
-- | -- | -- | -- | -- | -- |
|
FMED
Fidelity Disruptive Medicine ETF
|
-- | -- | -- | -- | -- | -- |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
-- | -- | -- | -- | -- | -- |
|
MEDI
Harbor Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
TMED
Trimedyne
|
-- | -- | -- | -- | -- | -- |
|
XLV
State Street Health Care Select Sector SPDR ETF
|
-- | -- | -- | -- | -- | -- |
Goldman Sachs Future Health Care Equity ETF vs. Competitors
-
Which has Higher Returns GDOC or FMED?
Fidelity Disruptive Medicine ETF has a net margin of -- compared to Goldman Sachs Future Health Care Equity ETF's net margin of --. Goldman Sachs Future Health Care Equity ETF's return on equity of -- beat Fidelity Disruptive Medicine ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- FMEDFidelity Disruptive Medicine ETF-- -- -- -
What do Analysts Say About GDOC or FMED?
Goldman Sachs Future Health Care Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Fidelity Disruptive Medicine ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Goldman Sachs Future Health Care Equity ETF has higher upside potential than Fidelity Disruptive Medicine ETF, analysts believe Goldman Sachs Future Health Care Equity ETF is more attractive than Fidelity Disruptive Medicine ETF.
Company Buy Ratings Hold Ratings Sell Ratings GDOCGoldman Sachs Future Health Care Equity ETF0 0 0 FMEDFidelity Disruptive Medicine ETF0 0 0 -
Is GDOC or FMED More Risky?
Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Fidelity Disruptive Medicine ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GDOC or FMED?
Goldman Sachs Future Health Care Equity ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.33%. Fidelity Disruptive Medicine ETF offers a yield of 0% to investors and pays a quarterly dividend of $0.11 per share. Goldman Sachs Future Health Care Equity ETF pays -- of its earnings as a dividend. Fidelity Disruptive Medicine ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDOC or FMED?
Goldman Sachs Future Health Care Equity ETF quarterly revenues are --, which are smaller than Fidelity Disruptive Medicine ETF quarterly revenues of --. Goldman Sachs Future Health Care Equity ETF's net income of -- is lower than Fidelity Disruptive Medicine ETF's net income of --. Notably, Goldman Sachs Future Health Care Equity ETF's price-to-earnings ratio is -- while Fidelity Disruptive Medicine ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Goldman Sachs Future Health Care Equity ETF is -- versus -- for Fidelity Disruptive Medicine ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- -- FMEDFidelity Disruptive Medicine ETF-- -- -- --
-
Which has Higher Returns GDOC or IBBQ?
Invesco Nasdaq Biotechnology ETF has a net margin of -- compared to Goldman Sachs Future Health Care Equity ETF's net margin of --. Goldman Sachs Future Health Care Equity ETF's return on equity of -- beat Invesco Nasdaq Biotechnology ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- -
What do Analysts Say About GDOC or IBBQ?
Goldman Sachs Future Health Care Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Nasdaq Biotechnology ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Goldman Sachs Future Health Care Equity ETF has higher upside potential than Invesco Nasdaq Biotechnology ETF, analysts believe Goldman Sachs Future Health Care Equity ETF is more attractive than Invesco Nasdaq Biotechnology ETF.
Company Buy Ratings Hold Ratings Sell Ratings GDOCGoldman Sachs Future Health Care Equity ETF0 0 0 IBBQInvesco Nasdaq Biotechnology ETF0 0 0 -
Is GDOC or IBBQ More Risky?
Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Invesco Nasdaq Biotechnology ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GDOC or IBBQ?
Goldman Sachs Future Health Care Equity ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.33%. Invesco Nasdaq Biotechnology ETF offers a yield of 0.87% to investors and pays a quarterly dividend of $0.09 per share. Goldman Sachs Future Health Care Equity ETF pays -- of its earnings as a dividend. Invesco Nasdaq Biotechnology ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDOC or IBBQ?
Goldman Sachs Future Health Care Equity ETF quarterly revenues are --, which are smaller than Invesco Nasdaq Biotechnology ETF quarterly revenues of --. Goldman Sachs Future Health Care Equity ETF's net income of -- is lower than Invesco Nasdaq Biotechnology ETF's net income of --. Notably, Goldman Sachs Future Health Care Equity ETF's price-to-earnings ratio is -- while Invesco Nasdaq Biotechnology ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Goldman Sachs Future Health Care Equity ETF is -- versus -- for Invesco Nasdaq Biotechnology ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- -- IBBQInvesco Nasdaq Biotechnology ETF-- -- -- --
-
Which has Higher Returns GDOC or MEDI?
Harbor Health Care ETF has a net margin of -- compared to Goldman Sachs Future Health Care Equity ETF's net margin of --. Goldman Sachs Future Health Care Equity ETF's return on equity of -- beat Harbor Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- MEDIHarbor Health Care ETF-- -- -- -
What do Analysts Say About GDOC or MEDI?
Goldman Sachs Future Health Care Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Harbor Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Goldman Sachs Future Health Care Equity ETF has higher upside potential than Harbor Health Care ETF, analysts believe Goldman Sachs Future Health Care Equity ETF is more attractive than Harbor Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings GDOCGoldman Sachs Future Health Care Equity ETF0 0 0 MEDIHarbor Health Care ETF0 0 0 -
Is GDOC or MEDI More Risky?
Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Harbor Health Care ETF has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GDOC or MEDI?
Goldman Sachs Future Health Care Equity ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.33%. Harbor Health Care ETF offers a yield of 0.24% to investors and pays a quarterly dividend of $0.08 per share. Goldman Sachs Future Health Care Equity ETF pays -- of its earnings as a dividend. Harbor Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDOC or MEDI?
Goldman Sachs Future Health Care Equity ETF quarterly revenues are --, which are smaller than Harbor Health Care ETF quarterly revenues of --. Goldman Sachs Future Health Care Equity ETF's net income of -- is lower than Harbor Health Care ETF's net income of --. Notably, Goldman Sachs Future Health Care Equity ETF's price-to-earnings ratio is -- while Harbor Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Goldman Sachs Future Health Care Equity ETF is -- versus -- for Harbor Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- -- MEDIHarbor Health Care ETF-- -- -- --
-
Which has Higher Returns GDOC or TMED?
Trimedyne has a net margin of -- compared to Goldman Sachs Future Health Care Equity ETF's net margin of --. Goldman Sachs Future Health Care Equity ETF's return on equity of -- beat Trimedyne's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- TMEDTrimedyne-- -- -- -
What do Analysts Say About GDOC or TMED?
Goldman Sachs Future Health Care Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Trimedyne has an analysts' consensus of -- which suggests that it could fall by --. Given that Goldman Sachs Future Health Care Equity ETF has higher upside potential than Trimedyne, analysts believe Goldman Sachs Future Health Care Equity ETF is more attractive than Trimedyne.
Company Buy Ratings Hold Ratings Sell Ratings GDOCGoldman Sachs Future Health Care Equity ETF0 0 0 TMEDTrimedyne0 0 0 -
Is GDOC or TMED More Risky?
Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Trimedyne has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock GDOC or TMED?
Goldman Sachs Future Health Care Equity ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.33%. Trimedyne offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Goldman Sachs Future Health Care Equity ETF pays -- of its earnings as a dividend. Trimedyne pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDOC or TMED?
Goldman Sachs Future Health Care Equity ETF quarterly revenues are --, which are smaller than Trimedyne quarterly revenues of --. Goldman Sachs Future Health Care Equity ETF's net income of -- is lower than Trimedyne's net income of --. Notably, Goldman Sachs Future Health Care Equity ETF's price-to-earnings ratio is -- while Trimedyne's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Goldman Sachs Future Health Care Equity ETF is -- versus -- for Trimedyne. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- -- TMEDTrimedyne-- -- -- --
-
Which has Higher Returns GDOC or XLV?
State Street Health Care Select Sector SPDR ETF has a net margin of -- compared to Goldman Sachs Future Health Care Equity ETF's net margin of --. Goldman Sachs Future Health Care Equity ETF's return on equity of -- beat State Street Health Care Select Sector SPDR ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- XLVState Street Health Care Select Sector SPDR ETF-- -- -- -
What do Analysts Say About GDOC or XLV?
Goldman Sachs Future Health Care Equity ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street Health Care Select Sector SPDR ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Goldman Sachs Future Health Care Equity ETF has higher upside potential than State Street Health Care Select Sector SPDR ETF, analysts believe Goldman Sachs Future Health Care Equity ETF is more attractive than State Street Health Care Select Sector SPDR ETF.
Company Buy Ratings Hold Ratings Sell Ratings GDOCGoldman Sachs Future Health Care Equity ETF0 0 0 XLVState Street Health Care Select Sector SPDR ETF0 0 0 -
Is GDOC or XLV More Risky?
Goldman Sachs Future Health Care Equity ETF has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison State Street Health Care Select Sector SPDR ETF has a beta of 0.656, suggesting its less volatile than the S&P 500 by 34.438%.
-
Which is a Better Dividend Stock GDOC or XLV?
Goldman Sachs Future Health Care Equity ETF has a quarterly dividend of $0.11 per share corresponding to a yield of 0.33%. State Street Health Care Select Sector SPDR ETF offers a yield of 1.59% to investors and pays a quarterly dividend of $0.66 per share. Goldman Sachs Future Health Care Equity ETF pays -- of its earnings as a dividend. State Street Health Care Select Sector SPDR ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios GDOC or XLV?
Goldman Sachs Future Health Care Equity ETF quarterly revenues are --, which are smaller than State Street Health Care Select Sector SPDR ETF quarterly revenues of --. Goldman Sachs Future Health Care Equity ETF's net income of -- is lower than State Street Health Care Select Sector SPDR ETF's net income of --. Notably, Goldman Sachs Future Health Care Equity ETF's price-to-earnings ratio is -- while State Street Health Care Select Sector SPDR ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Goldman Sachs Future Health Care Equity ETF is -- versus -- for State Street Health Care Select Sector SPDR ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income GDOCGoldman Sachs Future Health Care Equity ETF-- -- -- -- XLVState Street Health Care Select Sector SPDR ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 11.64% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.
